2942-13-4,MFCD01961206
Catalog No.:AA002Y95

2942-13-4 | 6-Methoxybenzothiazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
97%
in stock  
$7.00   $5.00
- +
1g
97%
in stock  
$11.00   $8.00
- +
5g
97%
in stock  
$35.00   $25.00
- +
10g
97%
in stock  
$68.00   $48.00
- +
25g
97%
in stock  
$170.00   $119.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA002Y95
Chemical Name:
6-Methoxybenzothiazole
CAS Number:
2942-13-4
Molecular Formula:
C8H7NOS
Molecular Weight:
165.2123
MDL Number:
MFCD01961206
SMILES:
COc1ccc2c(c1)scn2
NSC Number:
508406
Properties
Computed Properties
 
Complexity:
142  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2  

Upstream Synthesis Route

[1]BioorganicandMedicinalChemistryLetters,2008,vol.18,#20,p.5435-5438

[2]ChemicalandPharmaceuticalBulletin,1978,vol.26,#5,p.1443-1452

[3]J.Gen.Chem.USSR(Engl.Transl.),1981,vol.51,p.1822-1831

[4]ZhurnalObshcheiKhimii,1981,vol.51,#9,p.2116-2128

[5]Patent:WO2004/108694,2004,A1,.Locationinpatent:Page50

[6]Patent:WO2006/58700,2006,A1,.Locationinpatent:Page/Pagecolumn78

[7]Patent:WO2004/108663,2004,A1,.Locationinpatent:Page85

[1]Patent:US2004/19016,2004,A1,.Locationinpatent:Page/Pagecolumn66

[1]Patent:WO2017/218960,2017,A1,.Locationinpatent:Paragraph00453

[2]ChemicalandPharmaceuticalBulletin,1997,vol.45,#9,p.1547-1549

[3]BioorganicandMedicinalChemistryLetters,2008,vol.18,#20,p.5435-5438

[4]Tetrahedron,1997,vol.53,#50,p.17029-17038

[5]OrganicandBiomolecularChemistry,2017,vol.15,#10,p.2246-2252

[6]EuropeanJournalofOrganicChemistry,2010,#15,p.2849-2851

[7]BioorganicandMedicinalChemistryLetters,2010,vol.20,#6,p.1976-1980

[8]ChemicalandPharmaceuticalBulletin,1978,vol.26,#5,p.1443-1452

[9]JournalofMedicinalChemistry,1973,vol.16,p.1314-1316

[10]JournalofHeterocyclicChemistry,2000,vol.37,#6,p.1655-1658

[11]J.Gen.Chem.USSR(Engl.Transl.),1981,vol.51,p.1822-1831

[12]ZhurnalObshcheiKhimii,1981,vol.51,#9,p.2116-2128

[13]GazzettaChimicaItaliana,1964,vol.94,p.435-443

[14]Patent:WO2004/108694,2004,A1,.Locationinpatent:Page49-50

[15]Patent:WO2006/58700,2006,A1,.Locationinpatent:Page/Pagecolumn78

[16]JournalofMedicinalChemistry,2012,vol.55,#5,p.2469-2473

[17]Tetrahedron,2013,vol.69,#22,p.4436-4444

[18]OrganicLetters,2013,vol.15,#17,p.4600-4603

[19]Tetrahedron,2014,vol.70,#2,p.245-250

[20]OrganicandBiomolecularChemistry,2017,vol.15,#7,p.1606-1611

[21]Patent:WO2004/108663,2004,A1,.Locationinpatent:Page84-85

[1]Tetrahedron,2017,vol.73,#25,p.3438-3442

[2]RSCAdvances,2014,vol.4,#100,p.56957-56960

[3]ACSCatalysis,2015,vol.5,#11,p.6648-6652

[1]JournalofOrganicChemistry,2013,vol.78,#4,p.1471-1477

Downstream Synthesis Route

[1]JournaloftheAmericanChemicalSociety,1939,vol.61,p.2013,2016    JournaloftheAmericanChemicalSociety,1941,vol.63,p.2996,2999

[2]JournalofMedicinalChemistry,1973,vol.16,p.1314-1316

[3]JournalofMedicinalChemistry,1973,vol.16,p.1314-1316

[1]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.5435-5438

[2]ChemicalandPharmaceuticalBulletin,1978,vol.26,p.1443-1452

[3]JournalofgeneralchemistryoftheUSSR,1981,vol.51,p.1822-1831    ZhurnalObshcheiKhimii,1981,vol.51,p.2116-2128

[4]Patent:WO2004/108694,2004,A1.Locationinpatent:Page50

[5]Patent:WO2006/58700,2006,A1.Locationinpatent:Page/Pagecolumn78

[6]Patent:WO2004/108663,2004,A1.Locationinpatent:Page85

[1]GazzettaChimicaItaliana,1964,vol.94,p.435-443

[1]JournalofMedicinalChemistry,1973,vol.16,p.1314-1316

2942-13-4    50893-53-3    24850-33-7   
2-allyl-3-<(1-chloroethoxy)carbonyl>-6-methoxybenzothiazoline 

[1]JournalofOrganicChemistry,1994,vol.59,p.1319-1325

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:2942-13-4 Molecular Formula|2942-13-4 MDL|2942-13-4 SMILES|2942-13-4 6-Methoxybenzothiazole
Catalog No.: AA002Y95
2942-13-4,MFCD01961206
2942-13-4 | 6-Methoxybenzothiazole
Pack Size: 250mg
Purity: 97%
in stock
$7.00 $5.00
Pack Size: 1g
Purity: 97%
in stock
$11.00 $8.00
Pack Size: 5g
Purity: 97%
in stock
$35.00 $25.00
Pack Size: 10g
Purity: 97%
in stock
$68.00 $48.00
Pack Size: 25g
Purity: 97%
in stock
$170.00 $119.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA002Y95
Chemical Name: 6-Methoxybenzothiazole
CAS Number: 2942-13-4
Molecular Formula: C8H7NOS
Molecular Weight: 165.2123
MDL Number: MFCD01961206
SMILES: COc1ccc2c(c1)scn2
NSC Number: 508406
Properties
Complexity: 142  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2  
Upstream Synthesis Route
2942-13-4    13599-84-3 

[1]BioorganicandMedicinalChemistryLetters,2008,vol.18,#20,p.5435-5438

[2]ChemicalandPharmaceuticalBulletin,1978,vol.26,#5,p.1443-1452

[3]J.Gen.Chem.USSR(Engl.Transl.),1981,vol.51,p.1822-1831

[4]ZhurnalObshcheiKhimii,1981,vol.51,#9,p.2116-2128

[5]Patent:WO2004/108694,2004,A1,.Locationinpatent:Page50

[6]Patent:WO2006/58700,2006,A1,.Locationinpatent:Page/Pagecolumn78

[7]Patent:WO2004/108663,2004,A1,.Locationinpatent:Page85

2942-13-4    68867-18-5 

[1]Patent:US2004/19016,2004,A1,.Locationinpatent:Page/Pagecolumn66

1747-60-0    2942-13-4 

[1]Patent:WO2017/218960,2017,A1,.Locationinpatent:Paragraph00453

[2]ChemicalandPharmaceuticalBulletin,1997,vol.45,#9,p.1547-1549

[3]BioorganicandMedicinalChemistryLetters,2008,vol.18,#20,p.5435-5438

[4]Tetrahedron,1997,vol.53,#50,p.17029-17038

[5]OrganicandBiomolecularChemistry,2017,vol.15,#10,p.2246-2252

[6]EuropeanJournalofOrganicChemistry,2010,#15,p.2849-2851

[7]BioorganicandMedicinalChemistryLetters,2010,vol.20,#6,p.1976-1980

[8]ChemicalandPharmaceuticalBulletin,1978,vol.26,#5,p.1443-1452

[9]JournalofMedicinalChemistry,1973,vol.16,p.1314-1316

[10]JournalofHeterocyclicChemistry,2000,vol.37,#6,p.1655-1658

[11]J.Gen.Chem.USSR(Engl.Transl.),1981,vol.51,p.1822-1831

[12]ZhurnalObshcheiKhimii,1981,vol.51,#9,p.2116-2128

[13]GazzettaChimicaItaliana,1964,vol.94,p.435-443

[14]Patent:WO2004/108694,2004,A1,.Locationinpatent:Page49-50

[15]Patent:WO2006/58700,2006,A1,.Locationinpatent:Page/Pagecolumn78

[16]JournalofMedicinalChemistry,2012,vol.55,#5,p.2469-2473

[17]Tetrahedron,2013,vol.69,#22,p.4436-4444

[18]OrganicLetters,2013,vol.15,#17,p.4600-4603

[19]Tetrahedron,2014,vol.70,#2,p.245-250

[20]OrganicandBiomolecularChemistry,2017,vol.15,#7,p.1606-1611

[21]Patent:WO2004/108663,2004,A1,.Locationinpatent:Page84-85

124-38-9    6274-29-9    2942-13-4 

[1]Tetrahedron,2017,vol.73,#25,p.3438-3442

[2]RSCAdvances,2014,vol.4,#100,p.56957-56960

[3]ACSCatalysis,2015,vol.5,#11,p.6648-6652

119072-55-8    4274-42-4    2942-13-4 

[1]JournalofOrganicChemistry,2013,vol.78,#4,p.1471-1477

Downstream Synthesis Route
2942-13-4    30132-83-3 

[1]JournaloftheAmericanChemicalSociety,1939,vol.61,p.2013,2016    JournaloftheAmericanChemicalSociety,1941,vol.63,p.2996,2999

[2]JournalofMedicinalChemistry,1973,vol.16,p.1314-1316

[3]JournalofMedicinalChemistry,1973,vol.16,p.1314-1316

2942-13-4    13599-84-3 

[1]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.5435-5438

[2]ChemicalandPharmaceuticalBulletin,1978,vol.26,p.1443-1452

[3]JournalofgeneralchemistryoftheUSSR,1981,vol.51,p.1822-1831    ZhurnalObshcheiKhimii,1981,vol.51,p.2116-2128

[4]Patent:WO2004/108694,2004,A1.Locationinpatent:Page50

[5]Patent:WO2006/58700,2006,A1.Locationinpatent:Page/Pagecolumn78

[6]Patent:WO2004/108663,2004,A1.Locationinpatent:Page85

108-98-5    2941-59-5    2942-13-4 

[1]GazzettaChimicaItaliana,1964,vol.94,p.435-443

20265-97-8    2258-42-6    2942-13-4 

[1]JournalofMedicinalChemistry,1973,vol.16,p.1314-1316

2942-13-4    50893-53-3    24850-33-7   
2-allyl-3-<(1-chloroethoxy)carbonyl>-6-methoxybenzothiazoline 

[1]JournalofOrganicChemistry,1994,vol.59,p.1319-1325

Building Blocks More >
295328-85-7
295328-85-7
(2S,5S)-2,5-Diphenylpyrrolidine
AA002YKS | MFCD07772442
2965-07-3
2965-07-3
3,4-Bis(trifluoromethyl)aniline
AA002YXK | MFCD01312619
29739-88-6
29739-88-6
N-(p-Toluenesulfonyl)-L-phenylalanyl chloride
AA002Z6I | MFCD00191583
302964-02-9
302964-02-9
2-N-Boc-amino-thiazole-5-carboxylic acid
AA002ZGR | MFCD06796614
30354-91-7
30354-91-7
2,4-Diamino-6-(4-methoxyphenyl)-1,3,5-triazine
AA002ZRY | MFCD00889678
30448-04-5
30448-04-5
4,5,6-Trimethoxy-1H-indole
AA00302Y | MFCD00049062
30508-81-7
30508-81-7
(1-Methyl-piperidin-4-yl)-phenethyl-amine
AA0030CD | MFCD02105896
306387-90-6
306387-90-6
Benzenepropanamide, N-[6-[[2-[(3'R,3'aS,6'S,6aS,6bS,7'aR,2'R,11aS,11bR)-1,2,3,3',3'a,4,5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-3-oxospiro[9H-benzo[a]fluorene-9,2'(4'H)-furo[3,2-b]pyridin]-4'-yl]ethyl]amino]-6-oxohexyl]-
AA0030N4 | MFCD03425585
306936-37-8
306936-37-8
2-Methyl-5-(morpholinosulfonyl)-3-furoic acid
AA0030V1 | MFCD02180756
307554-62-7
307554-62-7
9,10-Anthracenedipropanoic acid, α9,α10-dicarboxy-
AA003145 | MFCD03095464
Submit
© 2017 AA BLOCKS, INC. All rights reserved.